BME
BlackRock Health Sciences Trust
Price Chart
Latest Quote
$39.84
-0.07 (-0.18%)
Current Price
| Previous Close | $39.91 |
| Open | $40.04 |
| Day High | $40.16 |
| Day Low | $39.63 |
| Volume | 21,955 |
Stock Information
| Quarterly Dividend / Yield | $3.15 / 7.82% |
| Shares Outstanding | 12.92M |
| Quarterly Dividend Yield | 7.82% |
| Quarterly Dividend | $3.15 |
| Total Debt | $894K |
| Cash Equivalents | $548 |
| Revenue | $7.74M |
| Net Income | $76.97M |
| Sector | Financial Services |
| Industry | Asset Management |
| Market Cap | $514.90M |
| P/E Ratio | 6.73 |
| EPS (TTM) | $5.92 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $520.70M |
| Sales | $7.74M |
| Income | $76.97M |
| Book/sh | $43.97 |
| Cash/sh | $0.00 |
Financial Ratios
| Quick Ratio | 0.23 |
| Current Ratio | 0.23 |
| Debt/Eq | 0.16 |
Returns & Margins
| ROA | 0.19% |
| ROE | 13.81% |
| Gross Margin | 100.00% |
| Operating Margin | 20.25% |
| Profit Margin | 994.98% |
Ownership
| Institutional Ownership | 20.61% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 66.56 |
| P/B | 0.91 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $39.80 |
| SMA50 | $39.20 |
| SMA200 | $38.45 |
| RSI | 48.30 |
| ATR | 0.6294 |
| Short Float | 0.39% |
| Short Ratio | 0.93 |
| Volatility | 0.59 |
| Rel Volume | 0.48 |
Performance History
| Week | -1.94% |
| Month | +2.73% |
| Quarter | +3.91% |
| 6 Months | +2.65% |
| YTD | +0.54% |
| Year | +20.88% |
| 3 Years | +23.50% |
| 5 Years | +16.02% |
| 10 Years | +119.60% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $39.84 | 21,955 |
| 2026-06-17 | $39.91 | 47,700 |
| 2026-06-16 | $40.22 | 38,000 |
| 2026-06-15 | $40.42 | 40,100 |
| 2026-06-12 | $40.68 | 45,600 |
| 2026-06-11 | $40.63 | 52,200 |
| 2026-06-10 | $40.05 | 49,500 |
| 2026-06-09 | $40.22 | 53,400 |
| 2026-06-08 | $39.94 | 42,700 |
| 2026-06-05 | $39.68 | 43,600 |
| 2026-06-04 | $39.61 | 41,200 |
| 2026-06-03 | $38.96 | 70,500 |
| 2026-06-02 | $39.08 | 67,500 |
| 2026-06-01 | $39.74 | 53,200 |
| 2026-05-29 | $39.97 | 41,800 |
| 2026-05-28 | $39.86 | 54,600 |
| 2026-05-27 | $39.41 | 27,100 |
| 2026-05-26 | $39.41 | 28,900 |
| 2026-05-22 | $39.36 | 63,400 |
| 2026-05-21 | $38.99 | 37,700 |
| 2026-05-20 | $39.02 | 44,700 |
| 2026-05-19 | $38.78 | 26,500 |
| 2026-05-18 | $38.38 | 61,700 |
About BlackRock Health Sciences Trust
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
đ° Latest News
How Closed-End Funds at a 12% Discount Can Turn $300,000 Into $30,000 a Year
24/7 Wall St. âĸ 2026-06-06T13:54:51Z
The Closed-End Fund Portfolio That Quietly Pays a 71-Year-Old $61,000 a Year on $850,000 and Trades at a Persistent Discount
24/7 Wall St. âĸ 2026-05-23T12:12:10Z
How The B&M European Value Retail (LSE:BME) Narrative Is Shifting After Analyst Recalibration
Simply Wall St. âĸ 2026-04-03T06:11:26Z
The Only Healthcare Stock I Would Buy and Never Sell Is Medtronic
Motley Fool âĸ 2026-02-21T15:05:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $77,535,845 | $24,071,879 | $20,410,615 | $-25,970,949 |
| Operating Revenue | $77,535,845 | $24,071,879 | $20,410,615 | $-25,970,949 |
| Expenses | ||||
| Interest Expense | $87 | $78 | $55 | - |
| Operating Expense | $566,628 | $617,092 | $393,597 | $500,130 |
| Other Operating Expenses | $127,575 | $261,566 | $94,571 | $137,966 |
| General And Administrative Expense | $439,053 | $355,526 | $299,026 | $362,164 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $76,969,217 | $23,454,787 | $20,017,018 | $-26,471,079 |
| Net Interest Income | $-87 | $-78 | $-55 | - |
| Interest Income | $0 | $0 | $0 | - |
| Normalized Income | $76,969,217 | $23,454,787 | $20,017,018 | $-26,471,079 |
| Net Income From Continuing And Discontinued Operation | $76,969,217 | $23,454,787 | $20,017,018 | $-26,471,079 |
| Net Income Common Stockholders | $76,969,217 | $23,454,787 | $20,017,018 | $-26,471,079 |
| Net Income | $76,969,217 | $23,454,787 | $20,017,018 | $-26,471,079 |
| Net Income Including Noncontrolling Interests | $76,969,217 | $23,454,787 | $20,017,018 | $-26,471,079 |
| Net Income Continuous Operations | $76,969,217 | $23,454,787 | $20,017,018 | $-26,471,079 |
| Pretax Income | $76,969,217 | $23,454,787 | $20,017,018 | $-26,471,079 |
| Special Income Charges | $0 | - | - | - |
| Per Share | ||||
| Diluted EPS | - | $1.63 | $1.44 | $-2.10 |
| Basic EPS | - | $1.63 | $1.44 | $-2.10 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Total Unusual Items | $0 | - | - | - |
| Total Unusual Items Excluding Goodwill | $0 | - | - | - |
| Diluted NI Availto Com Stockholders | $76,969,217 | $23,454,787 | $20,017,018 | $-26,471,079 |
| Restructuring And Mergern Acquisition | $0 | - | - | - |
| Gain On Sale Of Security | $28,423,697 | $28,761,252 | $26,702,159 | $13,672,574 |
| Selling General And Administration | $439,053 | $355,526 | $299,026 | $362,164 |
| Diluted Average Shares | - | $14,389,440 | $13,900,707 | $12,605,276 |
| Basic Average Shares | - | $14,389,440 | $13,900,707 | $12,605,276 |
Fetched: 2026-06-17
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $568,304,240 | $546,135,264 | $588,135,430 | $600,196,913 |
| Total Assets | $570,137,528 | $550,375,440 | $596,103,946 | $606,129,624 |
| Investmentin Financial Assets | $569,693,045 | $549,880,371 | $594,400,473 | $603,679,819 |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | $564,776,575 | $523,326,668 | $563,003,221 | $579,806,153 |
| Receivables | $428,138 | $404,422 | $1,615,047 | $2,368,513 |
| Taxes Receivable | $0 | - | - | - |
| Cash And Cash Equivalents | $548 | $6,048 | $534 | $3,118 |
| Cash Financial | $548 | $6,048 | $534 | $3,118 |
| Cash Cash Equivalents And Federal Funds Sold | $548 | $6,048 | $534 | $3,118 |
| Prepaid Assets | - | $0 | $5,292 | - |
| Debt | ||||
| Net Debt | - | $80,722 | $60,152 | $2,920 |
| Total Debt | - | $152,061 | $60,686 | $2,920 |
| Long Term Debt And Capital Lease Obligation | - | $152,061 | $60,686 | $2,920 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,833,288 | $4,240,176 | $7,968,516 | $5,932,711 |
| Derivative Product Liabilities | $0 | $2,822,101 | $7,272,745 | $4,323,328 |
| Payables | $919,894 | $1,124,278 | $621,390 | $892,029 |
| Other Payable | $707,935 | $631,171 | $621,390 | $658,831 |
| Accounts Payable | $211,959 | $493,107 | - | $233,198 |
| Equity | ||||
| Common Stock Equity | $568,304,240 | $546,135,264 | $588,135,430 | $600,196,913 |
| Total Equity Gross Minority Interest | $568,304,240 | $546,135,264 | $588,135,430 | $600,196,913 |
| Stockholders Equity | $568,304,240 | $546,135,264 | $588,135,430 | $600,196,913 |
| Retained Earnings | $210,691,745 | $165,001,984 | $170,517,630 | $175,896,846 |
| Other | ||||
| Ordinary Shares Number | $12,924,103 | $13,255,490 | $13,943,973 | $13,860,528 |
| Share Issued | $12,924,103 | $13,255,490 | $13,943,973 | $13,860,528 |
| Tangible Book Value | $568,304,240 | $546,135,264 | $588,135,430 | $600,196,913 |
| Capital Stock | $357,612,495 | $381,133,280 | $417,617,800 | $424,300,067 |
| Common Stock | $357,612,495 | $381,133,280 | $417,617,800 | $424,300,067 |
| Investments And Advances | $569,693,045 | $549,880,371 | $594,400,473 | $603,679,819 |
| Available For Sale Securities | $4,915,133 | $26,552,753 | $31,396,977 | $23,871,295 |
| Invested Capital | - | $768,719,076 | $588,196,116 | $600,199,833 |
| Total Capitalization | - | $768,719,076 | $588,196,116 | $600,199,833 |
Fetched: 2026-06-17
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $54,582,772 | $65,521,160 | $32,018,676 | $-874,045 |
| Operating Activities | ||||
| Operating Cash Flow | $54,582,772 | $65,521,160 | $32,018,676 | $-874,045 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-13,977,639 | $-29,532,715 | $0 | $0 |
| Financing Cash Flow | $-54,588,282 | $-65,515,639 | $-32,021,232 | $876,171 |
| Net Other Financing Charges | $0 | $0 | $0 | $0 |
| Cash Dividends Paid | $-40,610,643 | $-35,922,238 | $-35,099,184 | $-32,725,758 |
| Common Stock Dividend Paid | $-40,610,643 | $-35,922,238 | $-35,099,184 | $-32,725,758 |
| Net Common Stock Issuance | $-13,977,639 | $-29,532,715 | $3,020,683 | $33,618,939 |
| Issuance Of Capital Stock | - | - | $3,020,683 | $33,618,939 |
| Common Stock Issuance | - | - | $3,020,683 | $33,618,939 |
| Other | ||||
| End Cash Position | $548 | $6,048 | $534 | $3,118 |
| Beginning Cash Position | $6,048 | $534 | $3,118 | $960 |
| Effect Of Exchange Rate Changes | $10 | $-7 | $-28 | $32 |
| Changes In Cash | $-5,510 | $5,521 | $-2,556 | $2,126 |
| Common Stock Payments | $-13,977,639 | $-29,532,715 | $0 | $0 |
| Net Issuance Payments Of Debt | $0 | $-60,686 | $57,766 | $2,920 |
| Net Long Term Debt Issuance | $0 | $-60,686 | $57,766 | $2,920 |
| Change In Working Capital | $739,734 | $509,264 | $-765,401 | $325,082 |
| Change In Other Current Liabilities | $0 | $278,058 | $-675,895 | $464,323 |
| Change In Other Current Assets | $68,802 | $-1,999 | $-4,426 | $13,327 |
| Change In Accrued Expense | $3,323 | $2,044 | $-24,844 | $3,802 |
| Change In Payable | $76,764 | $9,962 | $-37,125 | $-9,484 |
| Change In Prepaid Assets | $0 | $5,292 | $-5,292 | $0 |
| Change In Receivables | $590,845 | $215,907 | $-17,819 | $-146,886 |
| Gain Loss On Investment Securities | $-23,126,179 | $41,557,109 | $12,767,059 | $25,271,952 |
| Net Income From Continuing Operations | $76,969,217 | $23,454,787 | $20,017,018 | $-26,471,079 |
| Issuance Of Debt | - | - | - | - |
| Long Term Debt Issuance | - | - | - | - |
Fetched: 2026-06-17